Concepedia

David A. Eavarone

DA

Statistics

Publications

6

Citations

1.3K

H-Index

6

Active since

2000

Affiliations

Harvard University(Current)

Massachusetts General Hospital

Siamab Therapeutics (United States)

Massachusetts Institute of Technology

Reproductive Science Center

David A. Eavarone is an author at Harvard University specializing in oncology, molecular oncology, and pharmacy.

ORCID

Publications per year

2000–2018

6

Publications

6

Temporal targeting of tumour cells and neovasculature with a nanoscale delivery system

Shiladitya Sengupta, David A. Eavarone, Ishan Capila et al. · Nature · 2005 · 943 citations

, , +16

Targeted drug delivery to C6 glioma by transferrin-coupled liposomes

David A. Eavarone, Xiaojun Yu, Ravi V. Bellamkonda · Journal of Biomedical Materials Research · 2000 · 119 citations

, , +17

Novel anti-Sialyl-Tn monoclonal antibodies and antibody-drug conjugates demonstrate tumor specificity and anti-tumor activity

Jillian M. Prendergast, David A. Eavarone, Darius Ghaderi et al. · mAbs · 2017 · 87 citations · Full text

, , +17

Humanized anti-Sialyl-Tn antibodies for the treatment of ovarian carcinoma

David A. Eavarone, Linah Al-Alem, Alexey A. Lugovskoy et al. · PLoS ONE · 2018 · 51 citations · Full text

, , +16

Treatment of ovarian cancer by targeting the tumor stem cell-associated carbohydrate antigen, Sialyl-Thomsen-nouveau

Kristen Starbuck, Linah Al-Alem, David A. Eavarone et al. · Oncotarget · 2018 · 42 citations · Full text

, , +15

1–5 of 6